How many stocks are there of Neuronetics?
The current number of stocks of Neuronetics is 28.66 M undefined.
Neuronetics Stocks 2024
Neuronetics Stocks
28.66 M
Neuronetics Dividend yield
Ticker
STIM
ISIN
US64131A1051
WKN
A2JPMY
In 2024, Neuronetics had 28.66 M outstanding stocks, a 0% change from the 28.66 M stocks in the previous year.
The Neuronetics Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2027e | 28.66 |
| 2026e | 28.66 |
| 2025e | 28.66 |
| 2024e | 28.66 |
| 2023 | 28.66 |
| 2022 | 26.9 |
| 2021 | 25.48 |
| 2020 | 18.84 |
| 2019 | 18.38 |
| 2018 | 8.95 |
| 2017 | 16.25 |
| 2016 | 16.25 |
Neuronetics Aktienanalyse
What does Neuronetics do?
Neuronetics Inc is a globally leading company in the field of non-invasive neuromodulatory technology. It was founded in 2003 and is headquartered in Malvern, Pennsylvania. The company specializes in the development and production of transcranial magnetic stimulation devices that can be used in the treatment of psychiatric disorders, particularly severe depression. Neuronetics' business model is based on selling its patented technology, called NeuroStar Advanced Therapy, to medical facilities worldwide. The company works closely with leading psychiatrists and clinical neurophysiologists to ensure that their devices meet the highest quality standards and can provide the best possible help to patients. The company has achieved a number of significant milestones in recent years. For example, in 2008, it received the first FDA approval for its technology. Since then, Neuronetics has continuously developed and improved its technology and has also obtained approvals in Europe and other parts of the world. Neuronetics is divided into various divisions, including research and development, manufacturing, and sales. Each of these departments is focused on ensuring the highest quality standards and ensuring that the technology of NeuroStar Advanced Therapy meets the needs of patients and medical personnel. The technology of NeuroStar Advanced Therapy is based on transcranial magnetic stimulation (TMS), which uses gentle magnetic fields to stimulate the activity of certain brain regions. The stimulation can help restore the balance of neurotransmitters in the brain and thus alleviate depression. Treatment with NeuroStar Advanced Therapy has significant advantages over conventional antidepressant medications. In many cases, it leads to faster improvement of symptoms and does not cause any of the undesirable side effects that can occur with medication. Overall, Neuronetics has developed a revolutionary technology with NeuroStar Advanced Therapy that can help millions of people around the world overcome their depression. The company is proud to contribute to improving the quality of life for people and will continue to develop innovative solutions in the field of neuromodulatory technology in the future. Neuronetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Neuronetics's Shares Outstanding
Neuronetics's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Neuronetics’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Neuronetics’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Neuronetics’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Neuronetics Stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Neuronetics are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Neuronetics evolved in recent years?
The number of shares of Neuronetics has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Neuronetics as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Neuronetics?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Neuronetics pay?
Over the past 12 months, Neuronetics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Neuronetics is expected to pay a dividend of 0 USD.
What is the dividend yield of Neuronetics?
The current dividend yield of Neuronetics is .
When does Neuronetics pay dividends?
Neuronetics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Neuronetics?
Neuronetics paid dividends every year for the past 0 years.
What is the dividend of Neuronetics?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Neuronetics located?
Neuronetics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Neuronetics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Neuronetics from 6/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/7/2024.
When did Neuronetics pay the last dividend?
The last dividend was paid out on 6/7/2024.
What was the dividend of Neuronetics in the year 2023?
In the year 2023, Neuronetics distributed 0 USD as dividends.
In which currency does Neuronetics pay out the dividend?
The dividends of Neuronetics are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Neuronetics
Our stock analysis for Neuronetics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Neuronetics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
